Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 10/29/19 → 9/15/21 |
Financiación
- Parexel International LLC: 144.851,00 US$
MG004: A Randomized, Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Efficacy of ROZANOLIXIZUMAB in Adult Patients with Generalized Myasthenia Gravis
- Mahuwala, Zabeen (PI)